Thank you to everyone who registered to participate in the precisionFDA Truth Challenge V2. We are excited to announce that the PacBio and Oxford Nanopore (Guppy v3.6) datasets for the Truth Challenge V2 are now live, and all the datasets needed to complete the challenge are now available on the challenge site! To accommodate the analysis of these datasets, we have extended the submission deadline for the challenge to June 8th.
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Yesterday, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM